PANAGORA ASSET MANAGEMENT INC

Position in CHRS — Coherus Oncology, Inc.

CIK 883677 Boston, MA

Position in CHRS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,592,255

-$873,978 QoQ

Shares Held

1,137,325

-22.1% QoQ

Ownership

0.736%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#15

of 145 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. CHRS ranks #44 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	175,291	$109,300,950
2	INCY	Incyte Corp	881,889	$99,970,937
3	XENE	Xenon Pharmaceuticals Inc.	664,031	$40,080,911
4	MIRM	Mirum Pharmaceuticals, Inc.	337,461	$39,506,559
5	TVTX	Travere Therapeutics, Inc.	490,724	$27,878,030
6	JAZZ	Jazz Pharmaceuticals plc	104,935	$25,286,186
7	RLAY	Relay Therapeutics, Inc.	1,291,182	$24,158,015
8	CLDX	Celldex Therapeutics, Inc.	572,538	$21,304,138

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,592,255	1,137,325	-22.1%	Shares	Sole	2026-08-06
2026-03-31	$2,466,233	1,459,310	-9.9%	Shares	Sole	2026-05-14
2025-12-31	$2,300,784	1,620,271	+17.8%	Shares	Sole	2026-02-13
2025-09-30	$2,256,587	1,375,968	+73.2%	Shares	Sole	2025-11-13
2025-06-30	$580,654	794,329	+322.3%	Shares	Sole	2025-08-13
2022-03-31	$2,428,293	188,094	+5.2%	Shares	Sole	2022-05-12
2021-12-31	$2,852,818	178,748	+162398.2%	Shares	Sole	2022-02-10
2021-06-30	$1,521	110	-96.5%	Shares	Sole	2021-08-11
2021-03-31	$45,364	3,105	0.0%	Shares	Sole	2021-05-12
2020-12-31	$53,964	3,105	0.0%	Shares	Sole	2021-02-10
2020-09-30	$56,945	3,105	0.0%	Shares	Sole	2020-11-13
2020-06-30	$55,455	3,105	-90.1%	Shares	Sole	2020-08-12
2020-03-31	$509,016	31,382	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.